The 2018 years Nobel prizes in Medicine (immuno oncology) manifested the power of biological drugs for treating life-threatening diseases, and the Nobel prize in Chemistry (phage-display) rewarded a technology that efficiently identifies potential biological drug candidates. Problem solved!? Not really! Much work remains in order to successfully move biological drug candidates to clinical trials. This one-day, free, workshop co-organized by the SciLifeLab Drug Discovery platform and GE Healthcare/Testa center will highlight some of the many activities that need to be in place to “Bridge the gap”.
Venue: GE Healthcare/Testa Center, Björkgatan 30, Uppsala
Registration and Coffee
Per Arvidsson and Anders Olsson, SciLifeLab
Trends in Biopharmaceuticals
Lotta Ljungqvist, GE Healthcare
Jesper Hedberg, Testa Center
Vinnova/Swedish Research Council: National research program on biologics; new methods, products and treatment options
Sandra Kleinau, Swedish Research Council
State of the art cell development, competence and costs
Ann Lövgren, GE Healthcare
Stefan Schmidt, BioAtrium
Lunch – including group visit to Testa Center
Ylva Skoglösa, Partner at Aera A/S, European Patent Attorney and Authorized Swedish Patent Attorney
Margareth Jorvid, Methra Uppsala AB / LSM Group
Taking a novel next-generation biologic drug to clinical proof of concept
Evelina Vågesjö & Peter Frank, Ilya Pharma
The Human Secretome Project
Hanna Tegel, KTH
Outsourcing process development and clinical manufacture-Challenges for the small biotech
Mikael Moge, BioArctic
Lotta Ljungqvist, Testa Center / GE Healthcare
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.